These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12356624)

  • 1. Background incidence of late malapposition after bare-metal stent implantation.
    Shah VM; Mintz GS; Apple S; Weissman NJ
    Circulation; 2002 Oct; 106(14):1753-5. PubMed ID: 12356624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional remodeling as the cause of late stent malapposition.
    Mintz GS; Shah VM; Weissman NJ
    Circulation; 2003 Jun; 107(21):2660-3. PubMed ID: 12771011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent implantation.
    Qian J; Zhang F; Wu H; Fan B; Ge L; Ge J
    Int J Cardiovasc Imaging; 2008 Feb; 24(2):133-9. PubMed ID: 17703294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
    Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
    Guo N; Maehara A; Mintz GS; He Y; Xu K; Wu X; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW
    Circulation; 2010 Sep; 122(11):1077-84. PubMed ID: 20805433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.
    Aoki J; Mintz GS; Weissman NJ; Mann JT; Cannon L; Greenberg J; Grube E; Masud AR; Koglin J; Mandinov L; Stone GW
    JACC Cardiovasc Interv; 2008 Apr; 1(2):161-7. PubMed ID: 19463294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose volume histogram assessment of late stent malapposition after intravascular brachytherapy.
    Dilcher CE; Chan RC; Pregowski J; Kalinczuk L; Mintz GS; Kotani J; Kruk M; Shah VM; Canos DA; Weissman NJ; Waksman R
    Cardiovasc Radiat Med; 2002; 3(3-4):190-2. PubMed ID: 12974372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late and very late drug-eluting stent malapposition: serial 2-year quantitative IVUS analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2010 Aug; 3(4):335-40. PubMed ID: 20606134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation.
    Hong SJ; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2015 Nov; 56(6):1538-44. PubMed ID: 26446634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of high pressure vs low pressure stent implantation on intimal hyperplasia and follow-up lumen dimensions; results of a randomized trial.
    Hoffmann R; Haager P; Mintz GS; Kerckhoff G; Schwarz R; Franke A; vom Dahl J; Hanrath P
    Eur Heart J; 2001 Nov; 22(21):2015-24. PubMed ID: 11603909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation.
    Hong MK; Mintz GS; Lee CW; Kim YH; Lee SW; Song JM; Han KH; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
    Circulation; 2004 Feb; 109(7):881-6. PubMed ID: 14967732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis.
    Degertekin M; Serruys PW; Tanabe K; Lee CH; Sousa JE; Colombo A; Morice MC; Ligthart JM; de Feyter PJ
    Circulation; 2003 Dec; 108(22):2747-50. PubMed ID: 14638542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
    Serruys PW; Degertekin M; Tanabe K; Abizaid A; Sousa JE; Colombo A; Guagliumi G; Wijns W; Lindeboom WK; Ligthart J; de Feyter PJ; Morice MC;
    Circulation; 2002 Aug; 106(7):798-803. PubMed ID: 12176950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravascular ultrasound assessment of chitosan/heparin layer-by-layer self assembly coating stent on late stent malapposition and vessel remodeling in porcine model].
    Shen L; Wu YZ; Zhang F; Sun AJ; Zhong W; Qian JY; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jul; 40(7):569-74. PubMed ID: 22943684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique.
    Hoffmann R; Mintz GS; Mehran R; Kent KM; Pichard AD; Satler LF; Leon MB
    Am J Cardiol; 1999 Apr; 83(8):1170-4. PubMed ID: 10215278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and mechanism of late stent malapposition after phosphorus-32 radioactive stent implantation.
    Kalinczuk L; Pregowski J; Mintz GS; Dilcher CE; Kotani J; Kruk M; Shah VM; Canos DA; Chan RC; Weissman NJ
    Am J Cardiol; 2003 Oct; 92(8):970-2. PubMed ID: 14556875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE).
    Kataoka T; Grube E; Honda Y; Morino Y; Hur SH; Bonneau HN; Colombo A; Di Mario C; Guagliumi G; Hauptmann KE; Pitney MR; Lansky AJ; Stertzer SH; Yock PG; Fitzgerald PJ
    Circulation; 2002 Oct; 106(14):1788-93. PubMed ID: 12356631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.